Apnicaf Oral Solution
Marketer
Abbott
Salt Composition
Caffeine (10mg)
Overview Apnicaf Oral Solution
PremaResp oral solution, a prescription medication, treats apnea (interrupted breathing) in premature infants. This medication promotes regular respiration and minimizes breathing pauses in premature newborns, administered only by healthcare providers orally or via feeding tube. Mothers breastfeeding infants treated with PremaResp should avoid caffeine consumption due to its transfer into breast milk. Potential side effects include agitation, sleep disturbances, cephalalgia, vertigo, and tachycardia. Persistent or worsening side effects warrant immediate medical consultation; your physician may offer strategies for mitigation.
Uses of Apnicaf Oral Solution
Respiratory pauses in premature infants
Major Benefits of Apnicaf Oral Solution:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Consult the product label for complete instructions prior to ingestion. Use a measuring device for accurate dispensing and consume orally. Ensure thorough shaking before each use. Apnicaf Oral Solution can be ingested with or without food; however, consistent daily timing is recommended.
Common Side effects of Apnicaf Oral Solution:
- Restlessness
- Headache
- Dizziness
- Increased heart rate
- Insomnia (difficulty in sleeping)
How to use Apnicaf Oral Solution:
Administer this medication according to your physician's prescribed dosage and schedule. Always consult the product label for instructions prior to consumption. Use a measuring device for accurate dosing and ingest orally. Ensure thorough shaking before each use. Apnicaf Oral Solution can be consumed with or without food; however, consistent timing is recommended.
How Apnicaf Oral Solution works:
Apnicaf Oral Solution acts as a respiratory stimulant. Its mechanism involves inhibiting adenosine and phosphodiesterase activity, thereby enhancing brain and respiratory function in premature infants. Consequently, it decreases apnea events and promotes independent breathing.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Apnicaf Oral Solution is unsafe.
PregnancyCONSULT YOUR DOCTOR
Use of Apnicaf Oral Solution during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the benefits against possible risks prior to prescription. Seek medical advice.
Breast feedingCAUTION
The use of Apnicaf Oral Solution while breastfeeding requires careful consideration. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Oral administration of Apnicaf may reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Apnicaf Oral Solution to individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Apnicaf Oral Solution's use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Apnicaf Oral Solution :
NA
Facts to Know About Apnicaf Oral Solution
| Label | Value |
|---|---|
| Chemical Type | Xanthine-based compound |
| Developing Habits | No. |
| Treatment Category | Heart |
| Actions | A1 and A2 adenosine receptor blocker |
3,018 People bought this recently